SCHEMBL7712411

SCHEMBL7712411

Nc1ncc(Oc2ccc(Cl)cc2)c(N2CCN(C(=O)CCC(=O)O)CC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 2/20 0.48
MDM2 Q00987 2/20 0.44
USP2 O75604 2/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HPGD P15428 3/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
RECQL P46063 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ENPP2 Q13822 2/20 0.41
KMT2A Q03164 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714367 0.92 PI4KB (0.48) PI4KBUSP2POLBALDH1A1HPGD
SCHEMBL7711739 0.90 PI4KB (0.48) PI4KBPOLBALDH1A1SMN1; SMN2HPGD
SCHEMBL7714374 0.86 PI4KB (0.58) PI4KBUSP2POLBALDH1A1SMN1; SMN2
SCHEMBL7712462 0.86 PI4KB (0.53) PI4KBPOLBSMN1; SMN2HPGDKDM4E
SCHEMBL7708563 0.84 PI4KB (0.46) PI4KBALDH1A1HPGDTRPA1
SCHEMBL7714727 0.83 ALDH1A1 (0.51) PI4KBALDH1A1HSD17B10KMT2AMEN1
SCHEMBL7714261 0.83 MAPT (0.50) PI4KBUSP2POLBALDH1A1SMN1; SMN2
SCHEMBL7714584 0.82 TRPA1 (0.55) PI4KBUSP2ALDH1A1HPGDCYP3A4
SCHEMBL7714733 0.81 PDGFRB (0.43) PI4KBMAPTLMNAMAPK1TRPA1
SCHEMBL7712369 0.79 DHFR (0.50) POLBALDH1A1SMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed